A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.
Cancer Med
; 11(22): 4169-4181, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-35499204
Full text:
1
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Adenocarcinoma
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Cancer Med
Year:
2022
Type:
Article
Affiliation country:
United States